Netarsudil Active Not Recruiting Phase 4 Trials for Open-angle Glaucoma (OAG) / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03808688Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting